299 related articles for article (PubMed ID: 28849110)
21. Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome.
Zhou L; Wang J; Wang T
BMC Med Genet; 2018 Jul; 19(1):121. PubMed ID: 30029625
[TBL] [Abstract][Full Text] [Related]
22. A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.
Corrêa FJ; Tavares AB; Pereira RW; Abrão MS
Fertil Steril; 2010 Feb; 93(3):1006.e3-6. PubMed ID: 19969293
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel mutation in FOXL2 gene that leads to blepharophimosis ptosis epicanthus inversus and telecanthus syndrome in a Tunisian consanguineous family.
Chouchene I; Derouiche K; Chaabouni A; Cherif L; Amouri A; Largueche L; Abdelhak S; El Matri L
Genet Test Mol Biomarkers; 2010 Feb; 14(1):145-8. PubMed ID: 19929410
[TBL] [Abstract][Full Text] [Related]
24. Screening of a large cohort of blepharophimosis, ptosis, and epicanthus inversus syndrome patients reveals a very strong paternal inheritance bias and a wide spectrum of novel FOXL2 mutations.
Bunyan DJ; Thomas NS
Eur J Med Genet; 2019 Jul; 62(7):103668. PubMed ID: 31077882
[TBL] [Abstract][Full Text] [Related]
25. FOXL2 gene mutations and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): a novel mutation detected in a Chinese family and a statistic model for summarizing previous reported records.
Xu Y; Lei H; Dong H; Zhang L; Qin Q; Gao J; Zou Y; Yan X
Mutagenesis; 2009 Sep; 24(5):447-53. PubMed ID: 19592504
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Tang S; Wang X; Lin L; Sun Y; Wang Y; Yu H
Mutagenesis; 2006 Jan; 21(1):35-9. PubMed ID: 16394030
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of the forkhead transcriptional factor 2 gene in three Chinese families with blepharophimosis syndrome.
Jiang H; Huang X; Su Z; Rao L; Wu S; Zhang T; Li K; Quan Q; Zhang K
Mol Vis; 2013; 19():418-23. PubMed ID: 23441113
[TBL] [Abstract][Full Text] [Related]
28. Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).
Gulati R; Verdin H; Halanaik D; Bhat BV; De Baere E
Eur J Med Genet; 2014 Oct; 57(10):576-8. PubMed ID: 25192944
[TBL] [Abstract][Full Text] [Related]
29. Seven Novel and Three Known Mutations in FOXL2 in 10 Chinese Families with Blepharophimosis Syndrome.
Lin B; Zeng B; Zhao J; Xu T; Wang Y; Hu B; Li F; Zhao Q; Liu R; Liu J; Chen JM; Huang D; Wang Y
Curr Mol Med; 2018; 18(3):152-159. PubMed ID: 30198434
[TBL] [Abstract][Full Text] [Related]
30. A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I.
Martinez-Aguayo A; Poggi H; Cattani A; Molina M; Romeo E; Lagos M
J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):181-4. PubMed ID: 24030029
[TBL] [Abstract][Full Text] [Related]
31. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
Kim JH; Bae J
J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With
Meng T; Zhang W; Zhang R; Li J; Gao Y; Qin Y; Jiao X
Front Endocrinol (Lausanne); 2022; 13():829153. PubMed ID: 35574016
[TBL] [Abstract][Full Text] [Related]
33. Blepharophimosis syndrome with absent tear production.
Ng JK; Stout AU; Aaby AA; Ng JD
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e62. PubMed ID: 24777257
[TBL] [Abstract][Full Text] [Related]
34. Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
Fan JY; Han B; Qiao J; Liu BL; Ji YR; Ge SF; Song HD; Fan XQ
Mutagenesis; 2011 Mar; 26(2):283-9. PubMed ID: 21068205
[TBL] [Abstract][Full Text] [Related]
35. [Blepharophimosis-ptosis-epicanthus inversus syndrome].
Lišková P; Ďuďáková Ľ; Diblík P
Cesk Slov Oftalmol; 2016; 72(5):187-190. PubMed ID: 28224805
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of forkhead transcriptional factor 2 (FOXL2) in Korean patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Cha SC; Jang YS; Lee JH; Kim HK; Kim SC; Kim S; Baek SH; Jung WS; Kim JR
Clin Genet; 2003 Dec; 64(6):485-90. PubMed ID: 14986827
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the transcription factor FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Li D; Zeng W; Tao J; Li S; Liang C; Chen X; Mu W; Wang X; Qin Y; Jie Y; Wei W
Genet Test Mol Biomarkers; 2009 Apr; 13(2):257-68. PubMed ID: 19371227
[TBL] [Abstract][Full Text] [Related]
38. Genomic Disruption of
Niu BB; Tang N; Xu Q; Chai PW
Chin Med J (Engl); 2018 Oct; 131(19):2380-2383. PubMed ID: 30246734
[No Abstract] [Full Text] [Related]
39. Mutation spectrum of fork-head transcriptional factor gene (FOXL2) in Indian Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) patients.
Kaur I; Hussain A; Naik MN; Murthy R; Honavar SG
Br J Ophthalmol; 2011 Jun; 95(6):881-6. PubMed ID: 21325395
[TBL] [Abstract][Full Text] [Related]
40. An individual with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and additional features expands the phenotype associated with mutations in KAT6B.
Yu HC; Geiger EA; Medne L; Zackai EH; Shaikh TH
Am J Med Genet A; 2014 Apr; 164A(4):950-7. PubMed ID: 24458743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
